Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	6.95	-36.53	-39.25
Graham Fair Price	-17.38	0.70	0.85
PEG	8900.14	0.19	< 0.005
Price/Book	48.27	-8.86	-17.12
Price/Cash Flow	50.47	-7.57	-15.28
Prices/Earnings	-35.26	-8.96	-6.63
Price/Sales	-22.76	9.09	11.76
Price/FCF	50.47	-7.57	-15.28
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	396.82	< 0.005	< 0.005
Operating Margin	-6.40	-0.43	-0.40
ROA	50.43	-0.04	-0.07
ROE	0.65	0.25	-61.75
ROIC	-0.13	-0.11	12.29
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	0.18	0.42	-55.94
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.38	0.05	-87.25
EPS QOQ	-31.56	0.47	-98.50
FCF QOQ	-0.27	-0.40	-47.93
Revenue QOQ	0.25	-0.11	-58.76
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	113.80	148.47	30.46
Days Sales Outstanding (DSO)	40.46	52.68	30.18
Inventory Turnover	0.79	0.61	-23.35
Debt/Capitalization	1.23	1.27	3.04
Quick Ratio	0.34	0.29	-13.21
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	-0.22	-0.30	-33.59
Cash	0.50	0.45	-10.06
Capex	-0.07	-0.03	58.72
Free Cash Flow	-0.25	-0.35	-39.54
Revenue	0.32	0.29	-10.53
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.59	0.55	-6.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-5.98	-9.71	-62.42
Naive Interpretation	Member

06 - Financial Health · Bad

Rating